Matricellular proteins in cardiac adaptation and disease.
about
Fatty old hearts: role of cardiac lipotoxicity in age-related cardiomyopathyHow Biomaterials Can Influence Various Cell Types in the Repair and Regeneration of the Heart after Myocardial InfarctionObesity, metabolic dysfunction, and cardiac fibrosis: pathophysiological pathways, molecular mechanisms, and therapeutic opportunitiesKeep your heart in shape: molecular chaperone networks for treating heart diseaseCross talk between cardiac myocytes and fibroblasts: from multiscale investigative approaches to mechanisms and functional consequencesTargeting myocardial remodelling to develop novel therapies for heart failure: a position paper from the Working Group on Myocardial Function of the European Society of CardiologyHypothyroidism and its rapid correction alter cardiac remodelingSPARC-Dependent Cardiomyopathy in Drosophila.Cardiac fibrosis in myocardial infarction-from repair and remodeling to regenerationDirect Thrombin Inhibitors Prevent Left Atrial Remodeling Associated With Heart Failure in RatsOsteopontin: At the cross-roads of myocyte survival and myocardial functionLoss of MicroRNA-155 protects the heart from pathological cardiac hypertrophyRole of sphingosine kinase/S1P axis in ECM remodeling of cardiac cells elicited by relaxinMyofibroblasts and the extracellular matrix network in post-myocardial infarction cardiac remodelingMatricellular proteins and matrix metalloproteinases mark the inflammatory and fibrotic response in human cardiac allograft rejection.The Soft- and Hard-Heartedness of Cardiac Fibroblasts: Mechanotransduction Signaling Pathways in Fibrosis of the Heart.Cardiac fibroblasts mediate IL-17A-driven inflammatory dilated cardiomyopathy.Expression profile of matricellular proteins in hypertrophied right ventricle of monocrotaline-induced pulmonary hypertensive rats.Periostin is upregulated in coronary arteriopathy in Kawasaki disease and is a potential diagnostic biomarker.Matricellular proteins and biomaterials.Parasite-derived neurotrophic factor/trans-sialidase of Trypanosoma cruzi links neurotrophic signaling to cardiac innate immune responseTranscriptional response to cardiac injury in the zebrafish: systematic identification of genes with highly concordant activity across in vivo models.Role of periostin, FENO, IL-13, lebrikzumab, other IL-13 antagonist and dual IL-4/IL-13 antagonist in asthma.Periostin in intrahepatic cholangiocarcinoma: pathobiological insights and clinical implications.A role for SPARC in the moderation of human insulin secretionThe dopamine D3 receptor knockout mouse mimics aging-related changes in autonomic function and cardiac fibrosisMechanisms involved in the beneficial effects of spironolactone after myocardial infarction.Effect and mechanism of thrombospondin-1 on the angiogenesis potential in human endothelial progenitor cells: an in vitro studyBisphenol A alters autonomic tone and extracellular matrix structure and induces sex-specific effects on cardiovascular function in male and female CD-1 mice.The inflammatory response in myocardial injury, repair, and remodelling.Thrombospondin-1 induction in the diabetic myocardium stabilizes the cardiac matrix in addition to promoting vascular rarefaction through angiopoietin-2 upregulation.Fibroblast growth factor-2 regulates human cardiac myofibroblast-mediated extracellular matrix remodelingObesity in a model of gpx4 haploinsufficiency uncovers a causal role for lipid-derived aldehydes in human metabolic disease and cardiomyopathy.Bioactive nanofibers enable the identification of thrombospondin 2 as a key player in enamel regeneration.Tracheal Aspirate Levels of the Matricellular Protein SPARC Predict Development of Bronchopulmonary DysplasiaCTGF/CCN2 Postconditioning Increases Tolerance of Murine Hearts towards Ischemia-Reperfusion Injury.Emerging roles for macrophages in cardiac injury: cytoprotection, repair, and regenerationExtracellular matrix and fibroblast communication following myocardial infarction.Diabetes-associated cardiac fibrosis: Cellular effectors, molecular mechanisms and therapeutic opportunities.Thrombospondins in the transition from myocardial infarction to heart failure.
P2860
Q26739009-FF804B2F-0E28-415A-A574-785ED11CC4A0Q26739723-A24374E9-ACAF-452B-938F-4AC7C6D5A197Q26825697-A64F0BB8-B839-4386-95CD-1A2266C3BF22Q27010429-6E33AADB-9684-4695-90A1-50D281B35C9CQ27021613-708F7F47-FC69-48AE-A4A9-4AE4CCDD6961Q27024879-ADF2E488-3F46-47D2-9706-EB8B5BC279FBQ27339180-78DB25D7-6481-4CBC-BFC3-A8C43BD63C80Q27340405-904EF94F-B55F-499C-B555-7FF6AB67B31FQ28068468-3AD22D81-6CA7-4C35-B5D2-3842195A239CQ28068706-3CF60909-D2A1-4639-88C9-66A94E6EC006Q28248833-E47FCAE6-5105-4330-BB47-D0771516BAE9Q28565486-8BC7B052-D83B-4BCE-AB33-32DDAB3CC133Q33631848-C736B4AB-B58C-4C46-893B-B40F62DBDBC5Q33663388-A59BBA3F-89CE-4007-8B6E-08BEEAC3DD21Q33732614-FD22CEA3-C048-4771-BE6C-C6782F15AF8CQ33737254-7A75436C-5F12-481F-8274-A41A48A8063CQ33826888-84B8AE24-F06C-46D0-AEF5-67D5FB7330BCQ33844110-8A4B850F-C595-4F86-A778-941F728F919EQ33864138-1110BD12-6E05-4CC5-8257-1171890D77E4Q34040283-4960DA5C-236A-4A92-A6CB-B2E8420B51C9Q34298453-EC845FEF-243E-463C-8120-38D1EE627DE8Q34339944-574F505E-2272-4132-9129-0C49FA1B4A8BQ34388348-BC9E023B-6EE8-4F25-843B-3E639158A58AQ34673957-01E40B47-8EF0-4EAD-82BC-0F3EE6EF1F01Q34808686-9C3184B2-92DA-40A6-8BEA-7EDBED970FCBQ34983783-C1ADBE33-9A51-4C48-A6AF-0C2906644A22Q35010403-6C550760-F3A9-4CD1-8AFC-DBD82B284151Q35088607-5AD41121-3F9B-4842-8E93-105FF348C429Q35088850-56113104-0E51-4049-B2EA-02B336EF0A1CQ35529656-881E4D6A-C3A7-4535-9EF4-708A42FB6A3FQ35534242-B032F7B8-0122-4B1E-83D9-6D3886CD1799Q35627274-2AA21D8D-0D87-4E7B-96BA-0CFACD71917EQ35644521-284809E9-5730-47E7-A123-110A78C1B13FQ35742861-99C97DBC-5349-460F-8473-7F81F4BDCC68Q35866210-96501A03-BF50-4F06-A6EF-7ED7BF70F084Q35922588-D6D259EB-F394-4877-9217-F297DF11E597Q36040543-FB42FDEC-0E0B-4C13-BDC4-9934F194586CQ36457257-A3E14172-B8D0-4746-A228-0C01EE614267Q36479405-9F29B969-E7A3-4E8E-991E-91A28D2B2ED7Q36479630-E015A06E-EAB4-445F-888E-9A8A4C1523B2
P2860
Matricellular proteins in cardiac adaptation and disease.
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Matricellular proteins in cardiac adaptation and disease.
@ast
Matricellular proteins in cardiac adaptation and disease.
@en
type
label
Matricellular proteins in cardiac adaptation and disease.
@ast
Matricellular proteins in cardiac adaptation and disease.
@en
prefLabel
Matricellular proteins in cardiac adaptation and disease.
@ast
Matricellular proteins in cardiac adaptation and disease.
@en
P2860
P1476
Matricellular proteins in cardiac adaptation and disease.
@en
P2093
Nikolaos G Frangogiannis
P2860
P304
P356
10.1152/PHYSREV.00008.2011
P577
2012-04-01T00:00:00Z